Clinical trial
Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have…
NCT00054522 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00054522 |
|---|---|
| Title | Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy |
| Official title | Calcitriol + Dexamethasone in Early, Recurrent Prostate Cancer Following Local Therapy, A Phase I/II Trial |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Dietary Supplement, Drug |
| Interventions | calcitriol, dexamethasone |
| Enrollment | 15 |
| Start date | Apr 1, 2002 |
| Primary completion | Jan 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | Feb 6, 2003 |
| Last update posted | Mar 8, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: